Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 2/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30428405 | 1.00 | CXCL8 (0.41) | CXCL8AKR1B1TSHRCES2CES1 | |
| SCHEMBL6864467 | 0.84 | CES2 (0.39) | CES2CES1CA1CA2CA4 | |
| SCHEMBL11035311 | 0.83 | CA1 (0.38) | CES2CES1CA1CA2CA4 | |
| SCHEMBL15092154 | 0.83 | AKR1B1 (0.41) | CXCL8AKR1B1TSHRCES2CES1 | |
| SCHEMBL28725225 | 0.83 | CES2 (0.38) | CES2CES1CA1CA2CA4 | |
| SCHEMBL23273525 | 0.82 | CXCL8 (0.38) | CXCL8AKR1B1TSHRMEN1POLB | |
| SCHEMBL29737965 | 0.82 | CXCL8 (0.38) | CXCL8AKR1B1TSHRMEN1POLB | |
| SCHEMBL3416130 | 0.82 | PTGS1 (0.44) | CXCL8TSHRMEN1POLBKMT2A | |
| SCHEMBL5062588 | 0.82 | PTGS1 (0.40) | CXCL8TSHRMEN1POLBKMT2A | |
| SCHEMBL1415207 | 0.82 | PTGS1 (0.40) | CXCL8AKR1B1TSHRHDAC6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118610580-A | Lithium ion battery electrolyte and lithium ion battery | 孚能科技(赣州)股份有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118610580-A | Lithium ion battery electrolyte and lithium ion battery | 孚能科技(赣州)股份有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-116209433-A | Small molecule albumin binding agents | 俄勒冈健康科学大学 | 2023-06-02 | — | — | CN | disclosed |
| US-6528517-B1 | Solid phase synthesis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2003-03-04 | — | — | US | disclosed |
| WO-1999040093-A2 | SYNTHESIS OF QUINOBENZOXAZINE ANALOGUES WITH TOPOISOMERASE II AND QUADRUPLEX INTERACTIONS FOR USE AS ANTINEOPLASTIC AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-08-12 | — | — | WO | disclosed |